PODD
INSULET CORP
NASDAQ · Healthcare · Medical - Devices · US
$161.53
+4.31%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$148.61
From 52W high−53.36%
Volume913170.00
Market cap$11.20B
P/E (TTM)30.1x
P/S (TTM)3.7x
Div yield—
Key dataNov 4, 2026
Open
$148.61
From 52W high
−53.36%
Volume
913170.00
Market cap
$11.20B
ValuationView details →
P/E (Fwd)
22.1x
EV/EBITDA
17.7x
P/E (TTM)
30.1x
RSI (14)
75.7
MomentumView details →
1D Return
+4.31%
YTD Return
−42.73%
SummaryUpdated Jun 1, 2026
Insulet Corporation (NASDAQ:PODD) is a medical device company founded in 2000 and headquartered in Acton, Massachusetts. The company went public in 2007 and has established itself as a leading innovator in diabetes care technology. Insulet specializes in developing, manufacturing, and selling tubeless insulin delivery systems for people with insulin-dependent diabetes. The company has grown from a startup focused on revolutionizing insulin pump technology to a global leader serving over 500,000 customers worldwide, with nine consecutive years of 20%+ revenue growth through 2024.
Similar companies
Latest newsMore news →
INSULET CORP reported quarterly earnings of $1.99 per share, compared with $1.24 per share a year earlier.3h agoInsulet reported third-quarter 2026 revenue of $842.0 million, up 19.2% year over year, or 19.6% in constant currency.5h agoInsulet announced the U.S. full market release of Omnipod Discover, a web-based data platform for Omnipod 5 users, caregivers and healthcare providers.23d ago